News

Brief news reports on Tuberculosis

UNAIDS releases latest AIDS report

On Monday the Joint United Nations Program on HIV/AIDS (UNAIDS) released a new report on the state of global AIDS, which shows that nearly half of people living with HIV/AIDS who qualify for treatment are receiving it.  The 2011 UNAIDS World AIDS Day Report estimates that 6.6 million of the estimated 14.2 million people eligible for treatment in low and middle income countries accessed antiretroviral therapy (ART) in 2010, in increase of 1.35 million since 2009.  The report also highlights that there are early signs that show scaling up ART is reducing the number of new HIV infections.

Read More →

Doha+10: MSF asks, what’s next for TRIPS and health?

For Médecins Sans Frontières (MSF, or Doctors Without Borders), the 10th anniversary of the Doha Declaration on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Public Health marks an opportunity to look forward.

Read More →

Vietnam aims to reduce TB patients by half in 2015

HO CHI MINH CITY, Nov 23 (Bernama) -- Vietnam will aim to halve the number of tuberculosis (TB) patients by 2015, towards achieving a goal of eliminating the disease in 2030.

Read More →

Resistant TB from inappropriate treatment

Results of a systematic review and meta-analysis lend further weight to the role of inappropriate treatment in the rise of multidrug resistant tuberculosis (MDR-TB).

Read More →

Uganda ranks among countries with high TB rate

With 102,000 new cases every year, Uganda is ranked sixteenth out of the 22 countries with the highest burden of tuberculosis (TB).

Read More →

TB/HIV activities: A look at Cambodia

Dr. Mean Chhi Vun, director of Cambodia’s National Center for HIV/AIDS, Dermatology and STDs (NCHADS), offered an exciting progress report to the TB/HIV Working Group of the Stop TB Partnership at their meeting last week in Beijing, including representatives from tuberculosis (TB) and HIV programs in China and elsewhere in the Pacific region.

Read More →

Lilly donates $4 million for tuberculosis drug discovery

Eli Lilly and Company (NYSE: LLY) today announced that it is providing more than $4 million in additional funding to the Infectious Disease Research Institute. The funding will allow IDRI to continue its early phase drug discovery efforts focused on identifying new and better therapies in the fight against tuberculosis, including multidrug-resistant strains known as MDR-TB. In addition, Lilly will provide more than $1 million in-kind for volunteer time from Lilly scientists and access to the company's drug discovery expertise, chemical libraries, and research tools.  

Read More →

No political will to support generic medication

South African health experts are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries.

Read More →

Russia to ban Tajik migration over HIV, TB threat

Russia may soon close its borders to immigrants from the Central Asian state of Tajikistan, according to Russia’s chief medical officer.

Read More →

A TB breakthrough: The "espresso" machine

MANILA, Philippines — The machine didn’t look like much. It was a little bigger than a breadbox and had a bunch of clear vials on top.

Read More →

Page 503 of 524 · Total posts: 10

←First 502 503 504 Last→